triazoles has been researched along with fh535 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alinger, B; Berr, F; Di Fazio, P; Fuereder, J; Kiesslich, T; Neureiter, D; Oberdanner, C; Ocker, M; Pichler, M; Wachter, J | 1 |
1 other study(ies) available for triazoles and fh535
| Article | Year |
|---|---|
Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells.
Topics: Antineoplastic Agents; Benzimidazoles; beta Catenin; Biliary Tract Neoplasms; Cadherins; Cell Line, Tumor; Cell Survival; Clinical Trials as Topic; Cyclin D1; Flavonoids; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Ki-67 Antigen; Proliferating Cell Nuclear Antigen; Quercetin; RNA, Messenger; Sulfonamides; Triazoles; Vimentin; Wnt Signaling Pathway | 2012 |